Achiko Logo cropped.jpg
Achiko AG Production and Sales Update
21 déc. 2022 07h42 HE | Achiko AG
AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests.Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match...
Achiko Logo cropped.jpg
AptameX Production and Commercialization Update
28 avr. 2022 08h15 HE | Achiko AG
Company has commenced shipping and will book first sales in May 2022Reorganized production line able to meet stronger than expected demand for Achiko AG’s innovative DNA aptamer saliva-based rapid...
Achiko Logo cropped.jpg
Achiko AG Production and Sales Update
03 mars 2022 07h30 HE | Achiko AG
Unique Chemistry with DNA Aptamers Completing Pre-Sales Validation TestingCompleting Pre-Sales Validation Testing in Indonesia ZURICH, Switzerland, March 03, 2022 (GLOBE NEWSWIRE) -- Ad...
Achiko Logo cropped.jpg
Achiko AG Research Paper and Commercialization Update
14 févr. 2022 07h30 HE | Achiko AG
Calibration study results now available in draft paper on medRxiv, a preprint platform for health sciences, as “DNA Aptamer Gold Nanoparticle Colorimetric Diagnostic Test Kit of Saliva Samples for...
Achiko Logo cropped.jpg
Achiko AG Strengthens Senior Team with Appointment of Head of Corporate Development
27 janv. 2022 07h30 HE | Achiko AG
Achiko AG appoints David Hodge to the role of Head of Corporate Development in SwitzerlandDavid Hodge will oversee Corporate Affairs, and Strategic and Corporate DevelopmentBoard Director Christophe...
Achiko Logo cropped.jpg
Achiko Secures Initial Sales of AptameX Covid-19 Diagnostic Test
27 oct. 2021 07h30 HE | Achiko AG
Achiko has received its first purchase order in Jakarta and Bali in Indonesia.The orders translate to 20,000 tests - while modest in size, the order is expected to pave the way to rapid adoption by...
Achiko Logo cropped.jpg
Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing
25 janv. 2021 07h30 HE | Achiko AG
Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO...
Achiko Logo cropped.jpg
Achiko Strengthens Leadership Team with New President and New SVP Commercialization
11 janv. 2021 07h30 HE | Achiko AG
Appoints New President, Biotechnology Research Scientist and Entrepreneur Dr. Morris S. Berrie Appoints New SVP Commercialization, Business Leader in Life Science Richard Lingard New Senior Leadership...
Pitt Street Research Initiates Coverage of Achiko AG - Highlights Novel Covid-19 Testing and Ecosystem Play
31 août 2020 08h00 HE | Achiko AG
SYDNEY, Australia, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Pitt Street Research, based in Sydney, Australia has issued an initial Evaluation Report on Achiko AG (SWX: ACHI) (ACHI.SW) (ISIN: CH0522213468)....